Carlo Russo
Chief Tech/Sci/R&D Officer bij GENENTA SCIENCE S.P.A.
Vermogen: 2 M $ op 31-03-2024
Profiel
Carlo Russo is currently the Chief Medical Officer & Head-Development at Genenta Science SpA since 2021.
Prior to this, he was the President & CEO at VaxInnate Corp.
He also served as the Chief Medical Officer & Executive Vice President at Adverum Biotechnologies, Inc. in 2016.
Dr. Russo holds a doctorate degree from the University of Genoa.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENENTA SCIENCE SPA
3.28% | 19-04-2023 | 598 417 ( 3.28% ) | 2 M $ | 31-03-2024 |
Actieve functies van Carlo Russo
| Bedrijven | Functie | Begin |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Chief Tech/Sci/R&D Officer | 01-01-2021 |
Eerdere bekende functies van Carlo Russo
| Bedrijven | Functie | Einde |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 01-07-2016 |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Chief Executive Officer | - |
Opleiding van Carlo Russo
| University of Genoa | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| GENENTA SCIENCE S.P.A. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
